Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

EPRX — Eupraxia Pharmaceuticals Inc. Dilution Risk Tracker

Track EPRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EPRX — Get alerts when the score changes →

As of October 13, 2026, Eupraxia Pharmaceuticals Inc. (EPRX) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Eupraxia Pharmaceuticals Inc. has a market capitalization of $260.90M, 35.64M shares outstanding, 54 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for EPRX.
🔔 Track EPRX — Get forecast alerts →

Market Data

Market Cap$260.90M
Shares Outstanding35.64M
FloatN/A
Cash$80.56M
Debt$2.01M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore36/100DilutionWatch score record
Shares Outstanding35.64MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$260.90MMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 73.8% shares (2026Q1 vs prior)
54 institutional holders · 24.11M shares
#1 Beutel, Goodman & Co Ltd. 3.67M shares
#2 Vivo Capital, LLC 2.70M shares
#3 Affinity Asset Advisors, LLC 1.59M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.80M
Days to Cover11.1
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual EPRX Dilution Snapshot

Eupraxia Pharmaceuticals Inc. (EPRX) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

EPRX's DilutionScore has held steady at 36/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202636/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

EPRX shares outstanding have increased 12.1% from 58.26M (Mar 2026) to 65.33M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 202665.33M50.32M▲ 7.69%
May 17, 202661.50M46.73M▲ 2.23%
May 15, 202661.50M45.71M▲ 0.50%
May 10, 202661.50M45.49M▼ 0.31%
Mar 30, 202661.50M45.63M▼ 0.09%
Mar 22, 202658.26M45.67M▼ 0.04%
Mar 19, 202658.26M45.69M▲ 0.80%
Mar 17, 202658.26M45.32M▲ 21.43%
Mar 05, 202658.26M37.33M▼ 0.38%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track EPRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment EPRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking EPRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for EPRX
EPRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.